All
Path:Home > News > All
2014 CPHI SHANGHAI
2014 CPHI SHANGHAI
More
62.8 billion national investment in biomedical biotechnology industry to promote the development of
May 13, the State Council Premier Wen Jiabao chaired a State Council executive meeting to study...
More
Pharmaceutical industry standards for water pollutants
August 1, "pharmaceutical industrial water pollutant discharge standards" to be implemented. According to industry experts, the new...
More
Bayer Schering Pharma AG to invest 100 million euros to establish R & D Center in China
According to reports, a subsidiary of Bayer AG - Bayer Schering Pharma AG, said in the next five years will invest 100 million euros in ...
More
Enzymes stitch together non-natural DNA
Researchers have found new ways to string together artificial DNA bases. The techniques could aid the creation of altered genetic material for applications in medicine and technology.
More
Enzyme promotes fat formation
The enzyme TPPII may contribute to obesity by stimulating the formation of fat cells, suggests a study in EMBO reports this week. The enzyme...
More

Copyright © 2016 Deyang Sinozyme Pharmaceutical Co., Ltd. All Rights Reserved